TY - JOUR
T1 - Temporal Control of the WNT Signaling Pathway During Cardiac Differentiation Impacts Upon the Maturation State of Human Pluripotent Stem Cell Derived Cardiomyocytes
AU - Tsoi, Chantelle
AU - Deng, Ruixia
AU - Kwok, Maxwell
AU - Yan, Bin
AU - Lee, Carrie
AU - Li, Hung Sing
AU - Ma, Chloe Ho Yi
AU - Luo, Ruibang
AU - Leung, Kam Tong
AU - Chan, Godfrey Chi Fung
AU - Chow, Larry Ming cheung
AU - Poon, Ellen N.
N1 - Funding Information:
This work was supported by funding from the direct grant (2019.038 and 2020.039) from the Chinese University of Hong Kong, the Children’s Cancer Foundation (6905997) and the Health and Medical Research Fund (06173796) to ENP.
Publisher Copyright:
Copyright © 2022 Tsoi, Deng, Kwok, Yan, Lee, Li, Ma, Luo, Leung, Chan, Chow and Poon.
PY - 2022/3/24
Y1 - 2022/3/24
N2 - Inefficient differentiation and insufficient maturation are barriers to the application of human pluripotent stem cell (hPSC)-derived cardiomyocytes (CMs) for research and therapy. Great strides have been made to the former, and multiple groups have reported cardiac differentiation protocol that can generate hPSC-CMs at high efficiency. Although many such protocols are based on the modulation of the WNT signaling pathway, they differ in their timing and in the WNT inhibitors used. Little is currently known about whether and how conditions of differentiation affect cardiac maturation. Here we adapted multiple cardiac differentiation protocols to improve cost-effectiveness and consistency, and compared the properties of the hPSC-CMs generated. Our results showed that the schedule of differentiation, but not the choice of WNT inhibitors, was a critical determinant not only of differentiation efficiency, which was expected, but also CM maturation. Among cultures with comparable purity, hPSC-CMs generated with different differentiation schedules vary in the expression of genes which are important for developmental maturation, and in their structural, metabolic, calcium transient and proliferative properties. In summary, we demonstrated that simple changes in the schedule of cardiac differentiation could promote maturation. To this end, we have optimized a cardiac differentiation protocol that can simultaneously achieve high differentiation efficiency and enhanced developmental maturation. Our findings would advance the production of hPSC-CMs for research and therapy.
AB - Inefficient differentiation and insufficient maturation are barriers to the application of human pluripotent stem cell (hPSC)-derived cardiomyocytes (CMs) for research and therapy. Great strides have been made to the former, and multiple groups have reported cardiac differentiation protocol that can generate hPSC-CMs at high efficiency. Although many such protocols are based on the modulation of the WNT signaling pathway, they differ in their timing and in the WNT inhibitors used. Little is currently known about whether and how conditions of differentiation affect cardiac maturation. Here we adapted multiple cardiac differentiation protocols to improve cost-effectiveness and consistency, and compared the properties of the hPSC-CMs generated. Our results showed that the schedule of differentiation, but not the choice of WNT inhibitors, was a critical determinant not only of differentiation efficiency, which was expected, but also CM maturation. Among cultures with comparable purity, hPSC-CMs generated with different differentiation schedules vary in the expression of genes which are important for developmental maturation, and in their structural, metabolic, calcium transient and proliferative properties. In summary, we demonstrated that simple changes in the schedule of cardiac differentiation could promote maturation. To this end, we have optimized a cardiac differentiation protocol that can simultaneously achieve high differentiation efficiency and enhanced developmental maturation. Our findings would advance the production of hPSC-CMs for research and therapy.
KW - cardiac differentiation
KW - cardiac maturation
KW - hPSC-CMs
KW - human pluripotent stem cell derived cardiomyocytes
KW - mitochondria
KW - wnt signalling pathway
UR - http://www.scopus.com/inward/record.url?scp=85128180571&partnerID=8YFLogxK
U2 - 10.3389/fmolb.2022.714008
DO - 10.3389/fmolb.2022.714008
M3 - Journal article
AN - SCOPUS:85128180571
SN - 2296-889X
VL - 9
JO - Frontiers in Molecular Biosciences
JF - Frontiers in Molecular Biosciences
M1 - 714008
ER -